The blood lipidome fatty acid profile predicts the disease risk and clinical phenotypes of Alzheimer’s disease: associations from two prospective cohort studies
7.5
来源：
Nature
关键字：
mRNA
发布时间：
2025-10-06 19:39
摘要：
This study developed and validated a blood fatty acid score (FAS) associated with Alzheimer's disease (AD) risk, utilizing data from two large cohorts in the UK and North America. The findings indicate that higher FAS correlates with increased AD risk and cognitive decline, particularly among APOE ε4 carriers. The research underscores the potential of blood fatty acids as biomarkers for early AD prediction and intervention, emphasizing the need for further studies to confirm these associations and explore underlying mechanisms.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分
business_impact
1.0分
scientific_rigor
1.5分
timeliness_innovation
1.5分
investment_perspective
2.5分
market_value_relevance
1.0分
team_institution_background
0.5分
technical_barrier_competition
0.0分
关键证据
Higher FAS was associated with increased AD risk in both cohorts.
The fatty acid score was validated using Lasso regression and Cox regression.
The study highlights potential biological mechanisms linking fatty acids to AD risk.
真实性检查
否
AI评分总结
This study developed and validated a blood fatty acid score (FAS) associated with Alzheimer's disease (AD) risk, utilizing data from two large cohorts in the UK and North America. The findings indicate that higher FAS correlates with increased AD risk and cognitive decline, particularly among APOE ε4 carriers. The research underscores the potential of blood fatty acids as biomarkers for early AD prediction and intervention, emphasizing the need for further studies to confirm these associations and explore underlying mechanisms.